{"id":"W2977439036","doi":"10.1093/annonc/mdz248.054","title":"A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metastatic prostate cancer (NCT03748641)","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Abiraterone acetate; Medicine; Prednisone; Abiraterone; Prostate cancer; Urology; Placebo; Internal medicine; Oncology; Cancer; Pathology; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002424065,0.00261628,0.004700058,0.0006834655,0.000825905,0.001321129,0.001597444,0.002243971,0.01205665],"category_scores_gemma":[0.002746935,0.001315005,0.002203442,0.0007738966,0.002037018,0.001420054,0.0005155577,0.005307186,0.00235509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001021394,"about_ca_system_score_gemma":0.002335575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001741469,"about_ca_topic_score_gemma":0.004535785,"domain_scores_codex":[0.9990289,0.000514984,0.00005697144,0.0002018875,0.00007211212,0.0001250612],"domain_scores_gemma":[0.9983957,0.00048952,0.0003208031,0.000153954,0.0001191786,0.0005208737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9864572,0.005439292,0.000123986,0.0003574024,0.0005761585,0.00001394109,0.00002809424,0.0001799887,0.001194947,0.00006748256,0.0005546411,0.005006724],"study_design_scores_gemma":[0.9824869,0.01660123,0.0002517138,0.00000944727,0.0001323164,0.000007996718,0.000007539552,0.0001213378,0.00007983356,0.00007915196,0.0002158792,0.000006519489],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9422175,0.008856126,0.003962078,0.002196686,0.003032882,0.02539066,0.005744576,0.0007013236,0.007898039],"genre_scores_gemma":[0.951479,0.004948908,0.006179222,0.003482589,0.001269262,0.01969232,0.002682406,0.0001057186,0.01016052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01205665,"threshold_uncertainty_score":0.04033351,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06863615528930514,"score_gpt":0.3932576299666062,"score_spread":0.3246214746773011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}